Seahorse Attenuated <scp>DSS</scp> ‐Induced Depression in Mice by Inhibiting Neuroinflammation and Ferroptosis

Pei‐Lu Chen, Ming Li, Xinyu Wang, Xiaonuan Qiu, F. Qiu, Liming Zheng, Li‐Tao Yi, Jiayuan Zhang, Guang‐Hui XuFood 2025 · DOI

TL;DR

This study investigates the therapeutic potential of seahorse extract in a mouse model of depression linked to inflammatory bowel disease (IBD). The research demonstrates that seahorse extract effectively alleviates both colitis symptoms and depressive behaviors by simultaneously targeting neuroinflammation and ferroptosis in the brain, offering a novel, multi-pronged approach to treating these interconnected conditions.

What Problem Does This Paper Address?

Depression is a debilitating psychiatric disorder with a significant global burden. While conventional treatments exist, their limitations necessitate the exploration of novel therapeutic avenues. Emerging research highlights a strong connection between systemic inflammation, particularly in the gut, and neuropsychiatric disorders like depression. Inflammatory bowel disease (IBD), characterized by chronic gut inflammation, is increasingly recognized as a comorbidity with depression. Dextran sulfate sodium (DSS)-induced colitis is a common animal model for IBD, and studies show it can lead to depressive-like behaviors. This is thought to occur through gut dysbiosis, elevated pro-inflammatory cytokines, and disrupted neurochemical signaling affecting brain function.

Furthermore, ferroptosis, a form of regulated cell death driven by iron and lipid peroxidation, has been implicated in depression pathophysiology. This process exacerbates oxidative stress and mitochondrial dysfunction, particularly in the hippocampus, a brain region critical for mood regulation. Therefore, there's a need for therapeutic agents that can simultaneously address both neuroinflammation and ferroptosis in the context of IBD-associated depression. Traditional Chinese medicine has utilized seahorse for its health-enhancing properties, but its specific mechanisms in mitigating neuroinflammation and ferroptosis in depression remained largely unexplored.

Methods

The researchers employed a multi-faceted approach to investigate the effects of seahorse extract:

  • Animal Model: Male C57BL/6 mice were used. Colitis and depression-like behaviors were induced using DSS in drinking water.
  • Behavioral Assessments:
    • Sucrose Preference Test: To assess anhedonia (loss of pleasure).
  • Forced Swimming Test: To measure despair-like behavior (immobility time).
  • Colitis Assessment:
    • Disease Activity Index (DAI): Daily monitoring of body weight loss, stool consistency, and fecal bleeding.
  • Colon Length Measurement: To assess macroscopic damage.
  • Histopathological Examination (H&E staining): To evaluate inflammation, crypt damage, and epithelial integrity in colonic tissues.
  • Molecular and Cellular Analysis:
    • Immunofluorescence Staining: To visualize and quantify the expression of key proteins related to inflammation (e.g., pNF-κB, NLRP3, TLR4, IL-1β, IL-6, TNF-α, Iba1 for microglia), neurogenesis (DCX), neuronal markers (NeuN), neurotrophic factors (BDNF), and ferroptosis pathways (pNrf2, HO-1, GPX4, SLC7A11) in both colonic and hippocampal tissues.
  • Transmission Electron Microscopy (TEM): To examine the ultrastructural changes in hippocampal neurons, specifically focusing on mitochondria (size, cristae integrity, number) and synaptic morphology (postsynaptic density, synaptic cleft width).
  • Biochemical Analysis:
    • HPLC Analysis: To determine the amino acid composition of the seahorse extract.

Datasets

Not discussed in the paper. The study primarily relies on experimental data generated from animal models and laboratory analyses.

Key Insights and Ideas

  • Dual Action of Seahorse: The most significant insight is seahorse extract's ability to simultaneously combat both neuroinflammation and ferroptosis, two critical pathways implicated in IBD-associated depression. This multi-target approach is a key differentiator from many conventional treatments.
  • Gut-Brain Axis Modulation: The study provides strong evidence for seahorse's efficacy in modulating the gut-brain axis. Alleviating colonic inflammation (as seen in improved DAI scores and histology) directly correlates with reduced depressive behaviors.
  • Hippocampal Protection: Seahorse extract demonstrates a protective effect on the hippocampus, a brain region highly vulnerable to stress and inflammation. This protection involves reducing microglial activation, suppressing pro-inflammatory signaling, promoting neurogenesis, and preserving mitochondrial and synaptic integrity.
  • Ferroptosis Inhibition: The research identifies seahorse's role in counteracting ferroptosis by upregulating key proteins like pNrf2, HO-1, GPX4, and SLC7A11. This suggests a novel mechanism for its antidepressant effects, distinct from traditional antidepressants.
  • Traditional Medicine Validation: The study provides scientific validation for the traditional use of seahorse in enhancing vitality and potentially treating mood-related disorders, by elucidating specific molecular mechanisms.

Key Results

  • Colitis Amelioration: Seahorse extract significantly reduced DSS-induced colitis symptoms, including weight loss, diarrhea, and fecal bleeding, as evidenced by improved DAI scores and better colonic histology. It also restored claudin-1 expression, indicating improved intestinal barrier function.
  • Depressive Behavior Reversal: Seahorse treatment effectively reversed DSS-induced depressive-like behaviors, significantly improving sucrose preference (reducing anhedonia) and decreasing immobility time in the forced swim test.
  • Neuroinflammation Suppression: In the hippocampus, seahorse extract reduced microglial activation (Iba1+ cells) and suppressed the expression of inflammatory markers like pNF-κB, NLRP3, TLR4, IL-1β, IL-6, and TNF-α.
  • Neurogenesis Promotion: Seahorse extract increased DCX+ cell numbers in the dentate gyrus, indicating enhanced neurogenesis, and elevated BDNF levels in the CA1 region, supporting neuronal survival and plasticity.
  • Ferroptosis Inhibition: Seahorse extract upregulated pNrf2, HO-1, GPX4, and SLC7A11 in the hippocampus, suggesting a potent antioxidative defense and inhibition of ferroptosis.
  • Mitochondrial and Synaptic Preservation: TEM analysis revealed that seahorse extract reversed DSS-induced mitochondrial atrophy and cristae deficiency, and preserved synaptic integrity in hippocampal neurons.

Limitations and Future Work

  • Amino Acid Contribution: While HPLC identified key amino acids in seahorse extract, their individual contributions to the observed therapeutic effects require further validation. The study suggests glycine and glutamate might play roles in anti-inflammatory and ferroptosis regulation, but specific mechanisms need deeper investigation.
  • Synergistic Effects: The study acknowledges that the therapeutic effects might arise from synergistic interactions between various components of seahorse extract, including amino acids, trace elements, and lipids. Isolating and testing individual components or specific combinations could provide more targeted insights.
  • Clinical Translation: The findings are based on a mouse model. Future work should focus on optimizing seahorse preparation for preservation of bioactive components, exploring nutrient-nutrient interactions, and conducting clinical trials to evaluate its translational potential in humans.
  • Conservation: The authors highlight the importance of seahorse conservation, implying that sustainable sourcing and ethical considerations are crucial for any future applications.

Summary updated

Abstract

Seahorse (<i>Hippocampus abdominalis</i>), a small fish, has been extensively utilized in traditional Chinese medicine to enhance and harmonize vital energy throughout the body and brain. This study aimed to elucidate the therapeutic role and underlying mechanism of seahorse in treating depressive symptoms. The therapeutic potential of seahorse was investigated in mice induced by dextran sulfate sodium (DSS) via behavioral tests, histopathological examinations, immunofluorescence staining, and transmission electron microscopy detection. Our findings revealed that seahorse effectively alleviated colitis symptoms by DSS, as shown by reduced inflammatory markers and enhanced expression of claudin-1 in the colonic tissues. More importantly, these gastrointestinal improvements were paralleled by significant attenuation of depressive behaviors, including improved anhedonia and reduced despair-like responses. Furthermore, seahorse exhibited a potent anti-inflammatory effect on brain tissues, evidenced by a decreased number of microglia in the hippocampal CA1 region, reduced expression of pNF-κB and NLRP3, and lowered cytokine levels. Additionally, seahorse promoted neurogenesis in the hippocampal DG region, enhanced brain-derived neurotrophic factor (BDNF) content in the CA1 region, and induced the pNrf2-mediated expression of HO-1, GPX4, and SLC7A11, collectively counteracting DSS-induced hippocampal ferroptosis. Transmission electron microscopy of mitochondria further confirmed that seahorse ameliorated DSS-induced mitochondrial atrophy and cristae deficiency. These results demonstrated that seahorse reversed IBD and comorbid depressive symptoms by regulating inflammation and ferroptosis. Our study highlights the multifaceted efficacy of seahorse in alleviating IBD and comorbid depressive symptoms, potentially offering a novel therapeutic avenue for these conditions.
BibTeX
@inproceedings{chen2025seahorse,
  author = {Pei‐Lu Chen and Ming Li and Xinyu Wang and Xiaonuan Qiu and F. Qiu and Liming Zheng and Li‐Tao Yi and Jiayuan Zhang and Guang‐Hui Xu},
  title = {{Seahorse Attenuated <scp>DSS</scp> ‐Induced Depression in Mice by Inhibiting Neuroinflammation and Ferroptosis}},
  booktitle = {Food},
  year = {2025},
  doi = {10.1002/fsn3.70482},
}
Figure